Table 2 Clinical and demographic characteristics
VES-13 < 3 | VES-13 ≥ 3 | Total | ||||
|---|---|---|---|---|---|---|
n = 104 | (%) | n = 102 | (%) | n = 206 | (%) | |
Male | 77 | (74) | 56 | (55) | 133 | (65) |
Age - years, median [range] | 72 | [65–84] | 77 | [65–89] | 73 | [65–89] |
Charlson comorbidity index, median [range] | 6 | [5–15] | 8 | [5–15] | 7 | [5–15] |
Diabetes mellitus | 29 | (28) | 33 | (32) | 62 | (30) |
Cardiovascular disease | 12 | (12) | 24 | (24) | 36 | (17) |
No. concomitant drugs, median [range] | 3 | [1–9] | 4 | [1–8] | 3 | [1–9] |
Primary cancer topography | ||||||
Colorectal | 66 | (64) | 64 | (63) | 130 | (63) |
Gastro-esophageal | 29 | (28) | 24 | (24) | 53 | (26) |
Pancreas | 3 | (3) | 10 | (10) | 13 | (6) |
Cancer stage (AJCC 7th edition) | ||||||
I | 9 | (9) | 8 | (8) | 17 | (8) |
II | 23 | (22) | 20 | (20) | 43 | (21) |
III | 43 | (42) | 34 | (33) | 77 | (37) |
IV | 22 | (21) | 34 | (33) | 56 | (27) |